bromfenac has been researched along with besifloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holland, EJ; Lane, SS | 1 |
| Duong, HV; Singleton, IC; Westfield, KC | 1 |
2 trial(s) available for bromfenac and besifloxacin
| Article | Year |
|---|---|
Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Anterior Chamber; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Benzophenones; Bromobenzenes; Cataract Extraction; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Glucocorticoids; Humans; Inflammation; Intraocular Pressure; Loteprednol Etabonate; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prednisolone; Topoisomerase II Inhibitors; Uveitis, Anterior; Visual Acuity | 2013 |
Treatment paradigm after uncomplicated cataract surgery: a prospective evaluation.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Benzophenones; Bromobenzenes; Cataract Extraction; Drug Therapy, Combination; Fluoroquinolones; Glucocorticoids; Humans; Macular Edema; Ophthalmic Solutions; Postoperative Complications; Practice Guidelines as Topic; Prednisolone; Prospective Studies; Single-Blind Method; Topoisomerase II Inhibitors; Uveitis, Anterior; Uveitis, Posterior | 2015 |